We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EU Regulator Stands Firm on PK Studies for Insulin Biosimilars
EU Regulator Stands Firm on PK Studies for Insulin Biosimilars
The European Medicines Agency has rejected calls from industry to use biosimilar reference products from outside the EU unless they are justified using pharmacokinetic tests.